Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

28.81 +0.25 (+0.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60,843
Open 28.99
Bid (Size) 28.00 (100)
Ask (Size) 29.24 (100)
Prev. Close 28.56
Today's Range 28.52 - 29.42
52wk Range 5.260 - 31.31
Shares Outstanding 78,614,114
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
Industry-leading QA/RA excellence accelerates patient access to Biodesix Lab testing, which helps improve overall outcomes for patients with lung nodules 
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Upcoming Investor Conferences
From Biodesix, Inc.
Via GlobeNewswire

Performance

YTD
+346.0%
+346.0%
1 Month
+29.0%
+29.0%
3 Month
+71.4%
+71.4%
6 Month
+76.7%
+76.7%
1 Year
+363.9%
+363.9%

More News

Read More
BioDesix (NASDAQ:BDSX) Passes Minervini Trend Template but Setup Quality Remains Weak ↗
Via Chartmill
News headline image
Biodesix (BDSX) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Biodesix (NASDAQ:BDSX) Q2 EPS Beats, Revenue In Line, Shares Slip ↗
Via Chartmill
Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance ↗
Via Chartmill
Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability ↗
Via Chartmill
Topics Earnings
News headline image
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference ↗
Via MarketBeat
News headline image
Biodesix Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Biodesix Announces Second Quarter 2026 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Upcoming Investor Conferences
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix (BDSX) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Biodesix BDSX Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Biodesix Announces First Quarter 2026 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Recognized as a Top Workplace for Third Consecutive Year
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix (BDSX) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Upcoming Investor Conferences
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
From Biodesix, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Biodesix, Inc. - Common Stock publicly traded?
Yes, Biodesix, Inc. - Common Stock is publicly traded.
What exchange does Biodesix, Inc. - Common Stock trade on?
Biodesix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Biodesix, Inc. - Common Stock?
The ticker symbol for Biodesix, Inc. - Common Stock is BDSX on the Nasdaq Stock Market
What is the current price of Biodesix, Inc. - Common Stock?
The current price of Biodesix, Inc. - Common Stock is 28.81
When was Biodesix, Inc. - Common Stock last traded?
The last trade of Biodesix, Inc. - Common Stock was at 09/17/26 04:00 PM ET
What is the market capitalization of Biodesix, Inc. - Common Stock?
The market capitalization of Biodesix, Inc. - Common Stock is 2.26B
How many shares of Biodesix, Inc. - Common Stock are outstanding?
Biodesix, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.